BridgeBio Pharma (BBIO) - News Mentions

Sign up to add (BBIO) to your portfolio and access more historical data.

00%
Est. daily news mentions.
Loading...

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 0 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Analysts Remain Positive on BridgeBio Pharma, Inc. (BBIO) After Strong 2025 Results
January 20
BridgeBio Pharma, Inc. (BBIO) Presents at 44th Annual J.P. Morgan Healthcare Conference Prepared Remarks Transcript
January 11
BridgeBio Pharma, Inc. (BBIO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
January 11
BridgeBio Pharma, Inc. (BBIO) Discusses Achondroplasia Pathophysiology, Unmet Needs, and PROPEL 3 Infigratinib Phase 3 Study - Slideshow
January 8
BridgeBio Pharma, Inc. (BBIO) Discusses Achondroplasia Pathophysiology, Unmet Needs, and PROPEL 3 Infigratinib Phase 3 Study Transcript
January 8
Skeletal Dysplasia Market Analysis Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
January 23
Dystrophic Epidermolysis Bullosa Global Clinical Trials Market Review Report 2025
January 16
BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027
January 15
BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027
January 14
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
January 12
BridgeBio to Participate in the J.P. Morgan Healthcare Conference
January 5
BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET
January 2

Month over Month

Est. daily news mentions.

Dec 2025 0
Nov 2025 0
Oct 2025 0
Sep 2025 0

How often is BridgeBio Pharma mentioned in the news?

BridgeBio Pharma was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is BridgeBio Pharma performing compared to its industry peers?

BridgeBio Pharma underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of BridgeBio Pharma in the last month?

There has been no significant change in the number of news mentions for BridgeBio Pharma's compared to the last month.

Why is it important to track news mentions for BridgeBio Pharma?

By monitoring mentions in the news for BridgeBio Pharma, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of BridgeBio Pharma, ultimately improving their investment strategies.

Sign up and get more insights on BridgeBio Pharma.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About AltIndex

Smarter investing with alternative data analytics and AI-powered insights.

Download on the App Store Get it on Google Play
Company
Features
More Data
© 2026 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.